Febuxostat (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Febuxostat" in French language version.

refsWebsite

Global rank French rank

2thelancet.com

2,393^rd place

506^th place

2nejm.org

2,374^th place

298^th place

1qmul.ac.uk

1,735^th place

168^th place

1nih.gov

4^th place

12^th place

1lww.com

2,769^th place

931^st place

1wiley.com

222^nd place

129^th place

1medicaments.gouv.fr

low place

2,794^th place

1europa.eu

68^th place

67^th place

europa.eu

ec.europa.eu

Annexe 1, Résumé des caractéristiques du produit publié en Europe sous la référence EU/1/08/447

lww.com

journals.lww.com

(en) Mayer MD, Khosravan R, Vernillet L, Wu JT, Joseph-Ridge N, Mulford DJ, « Pharmacokinetics and pharmacodynamics of febuxostat, a new selective nonpurine inhibitor of xanthine oxidase, in subjects with renal impairment » Am J Ther. 2005;12:22-34.

medicaments.gouv.fr

base-donnees-publique.medicaments.gouv.fr

Résumé des caractéristiques du produit RCP n^o 347 page 669

nejm.org

(en) Becker MA, Schumacher HR, Wortmann RL et al. « Febuxostat compared with allopurinol in patients with hyperuricemia and gout » N Engl J Med. 2005;353:2450-61.
White WB, Saag KG, Becker MA et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout, N Eng J Med, 2018;378:1200-1210

nih.gov

ncbi.nlm.nih.gov

(en) Takano Y, Hase-Aoki K, Horiuchi H et al. « Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase » Life Sci. 2005;76:1835-47. PMID 15698861

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

thelancet.com

(en) Burns CM, Wortmann RL, « Gout therapeutics: new drugs for an old disease » Lancet 2011;377:165-177
Mackenzie IS, Ford I, Nuki G et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial, Lancet, 2020;396:1745-1757

wiley.com

onlinelibrary.wiley.com

(en) Schumacher HR, Becker MA, Wortmann RL et al. « Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel group trial » Arthritis Care Res. 2008;59:1540-8.